Benutzerspezifische Werkzeuge

Offene Studien adjuvant

NameTitel
ADAPTCycle

Adjuvant Dynamic marker-Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer (ADAPTcycle)